FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Effects of Recombinant Replacement Therapy Explained in Detailed Regarding Genetic Clotting Disorder.

2.

Tumor characteristics found to differ for melanomas in children, teens and young adults

3.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

4.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

5.

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot